OrthoPediatrics announced that it completed the acquisition of ApiFix for $2 million in cash and nearly 1 million shares of OrthoPediatrics’ common stock. Warsaw, Ind.–based OrthoPediatrics’ purchase includes the cash, 934,768 shares of common stock and milestone payments and an earnout over four years. Israel- and Boston-based ApiFix develops a minimally invasive deformity correction (MID-C) […]
OrthoPediatrics launches Large Fragment Cannulated Screw System
OrthoPediatrics this week said it launched its Large Fragment Cannulated Screw System in the U.S. The screw system is designed to address trauma procedures and treat children with Slipped Capital Femoral Epiphysis. The system features screws in 2mm increments, screw thread run out in the head of the screw, dual lead threads and threaded cannulation. […]
OrthoPediatrics sells off Vilex assets related to adults
OrthoPediatrics (NSDQ:KIDS) announced today that it completed the sale of substantially all of the assets related to the adult product offering of Vilex in Tennessee to Squadron Capital affiliate Vilex. The divestiture was completed on Dec. 31, 2019, after OrthoPediatrics reported its plan to divest the Vilex adult business when it acquired Vilex in Tennessee in […]
OrthoPediatrics launches PediFoot system
OrthoPediatrics (NSDQ:KIDS) announced the U.S. launch of its PediFoot deformity correction system for feet after it won FDA 510(k) clearance months ago. The Warsaw, Ind.–based company picked up FDA approval in August for the PediFoot, which it said is the first pediatric-specific system for treating foot deformities. PediFoot utilizes plates and screws that are smaller than […]
AtriCure falls despite solid Q4, 2018 prelims | Wall Street Beat
AtriCure (NSDQ:ATRC) shares took a fall today despite preliminary results for the fourth quarter and 2018 that topped estimates. The Mason, Ohio-based cardiac implant maker said it expects to post Q4 sales of $52.9 million and 2018 sales of $201.6 million, beating the consensus estimatyes on Wall Street for both periods. “We are pleased with our […]
OrthoPediatrics announces pricing of common stock offering
OrthoPediatrics (NSDQ:KIDS) said today it will price an underwritten follow-on public offering of 1.5 million shares of its common stock at $27 per share. The company said it plans to use the proceeds of offering to invest in implant and instrument sets for consignment to its customers, fund research and development activities, expand its sales and […]
OrthoPediatrics expands Indiana-based headquarters
OrthoPediatrics said yesterday it is planning a $1 million expansion of its Warsaw, Ind.-based headquarters, looking to double its warehouse space and add administrative spaces. The expansion will include the addition of open-concept offices and dedicated training and education facilities, the company said. A ground-breaking on the expansion is being held on August 16. “Indiana is […]
OrthoPediatrics announces Femur pediatric nailing platform FDA nod, Q1 earnings
OrthoPediatrics this week announced it won FDA 510(k) clearance for its Femur pediatric nailing platform and released its first quarter earnings, beating sales consensus but missing on loss-per-share expectations on Wall Street. The Warsaw, Ind.-based company’s Femur system is designed to accompany two pediatric-specific nail offerings, and is an upgrade to an earlier version of the […]
OrthoPediatrics launches pediatric wrist fusion plate
OrthoPediatrics said yesterday it launched its pediatric-specific wrist fusion plate system as part of its PediFrag franchise. The wrist fusion plate system includes plates in two implant lengths to accomodate patients with and without proximal row carpectomies and features low-profile stainless steel plates to minimize plate prominence and reduce soft-tissue irritation, the Warsaw, Ind.-based company said. […]
OrthoPediatrics prices $52m IPO
OrthoPediatrics today priced its initial public offering at $13 per share, meaning the 4-million-share flotation pulled in $52 million for its line of surgical systems for children. The offering includes a 30-day underwriters over-allotment of 600,000 extra shares, which if fully exercised would push the IPO’s total raise to $59.8 million. Warsaw, Ind.-based OrthoPediatrics produces 21 surgical […]
OrthoPediatrics sets price range on IPO, could bring in up to $64m
OrthoPediatrics yesterday priced the range on its initial public offering, looking to float 4 million shares of common stock at between $12 and $14 per share, which would bring in between $48 and $56 million. The offering also includes a 30-day underwriter’s option to purchase an additional 600,000 shares of common stock, bringing the possible […]
